Home Neoplasma 2011 Neoplasma Vol.58, No.1, p.58-64, 2011

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.58, No.1, p.58-64, 2011

Title: Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus
Author: T. KRECHLER, M. ZEMAN, M. VECKA, J. MACASEK, M. JACHYMOVA, T. ZIMA, A. ZAK

Abstract: The aim of this study was to analyze the relationship of serum leptin as well as adiponectin and the manifestation of pancreatic cancer (PC).  Serum leptin, adiponectin, glucose homeostasis and insulin resistance (expressed as HOMA-IR) were investigated in 64 patients with newly diagnosed PC and compared with 64 healthy controls (CON group) and 75 patients with type 2 diabetes (DM2).
Seventy percent of newly diagnosed PC patients had DM2. The levels of leptin were lower, whilst adiponectin/leptin ratio was higher in PC patients (both with and without DM2), in comparison with CON and DM2 groups (P < 0.001) independently of age, BMI and waist circumference.
Newly diagnosed PC is characterized with lower leptin concentrations and higher adiponectin/leptin ratio in comparison with CON or DM2 individuals. Analysis of these parameters could help in the screening of persons in high risk for PC, especially in those with DM2.

Keywords: adiponectin, leptin, pancreatic cancer, type 2 diabetes mellitus
Year: 2011, Volume: 58, Issue: 1 Page From: 58, Page To: 64
doi:10.4149/neo_2011_01_58
Price: 16.80 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.